Global Partners LP
GLP
Updated: 22/09/2026, 15:05:10
Global Partners LP engages in the purchasing, selling, gathering, blending, storing, and logistics of transporting gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, and propane to wholesalers, retailers, and commercial customers. The company operates through three segments: Wholesale, Gasoline Distribution and Station Operations (GDSO), and Commercial. The Wholesale segment sells home heating oil, branded and unbranded gasoline and gasoline blendstocks, diesel, kerosene, and residual oil to retailers and wholesale distributors. This segment transports the products by railcars, barges, trucks and/or pipelines. The GDSO segment sells branded and unbranded gasoline to gasoline station operators and sub-jobbers; operates convenience stores and prepared food sales; and provides car wash, lottery, and ATM services, as well as leases gasoline stations. The Commercial segment sells and delivers unbranded gasoline, home heating oil, diesel, kerosene, residual oil, and bunker fuel to customers in the public sector; and sells custom blended fuels. The company is involved in the transportation of petroleum products and renewable fuels through rail from the mid-continent region of the United States and Canada. Global Partners LP was founded in 2005 and is based in Waltham, Massachusetts.
No summaries found.
- Share price
- $50.62
- Market cap
- $1.72B
- Exchange
- NYSE
- Currency
- USD
- CEO
- Eric Slifka
- Employees
- 4,700
- IPO date
- 04/10/2005
- Beta
- 1.054
- Last dividend
- $0.00
- Day range
- $48.96 – $50.63
- 52-week range
- $39.58 – $54.29
- 1-day performance
- 3.35%
- 1-year performance
- 27.89%
- Current drawdown (1Y)
- -6.76%
- CIK
- 0001323468
- CUSIP
- 37946R109
- ISIN
- US37946R1095
- Created
- 07/12/2025, 04:15:24
- Last update
- 22/09/2026, 15:05:10
Track Global Partners LP with an AI analyst
See which prediction-market events move GLP, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Novo Nordisk: Wegovy® pill (semaglutide tablets) becomes first daily GLP-1 weight-loss pill approved in the UK
GlobeNewsWire • STOCK • 11/06/2026, 13:03:00
The GLP-1 stock nobody is pricing in isn't a drugmaker
24/7 Wall Street • STOCK • 11/06/2026, 11:30:53
Some US employers to drop coverage of GLP-1 obesity drugs in 2027 as use increases
Reuters • STOCK • 11/06/2026, 08:03:25
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market
Zacks Investment Research • STOCK • 10/06/2026, 15:01:19
Novo Nordisk CEO: '80% of Wegovy pill customers' have never taken a GLP-1 before
CNBC Television • STOCK • 09/06/2026, 16:42:38
Gen Z and GLP-1 drugs to power Gym Group's growth, says analyst
Proactive Investors • STOCK • 09/06/2026, 13:42:20
Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway
Accesswire • STOCK • 09/06/2026, 11:25:00
Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying
Forbes • STOCK • 09/06/2026, 11:20:23
Promino Launches Muscle Health Research Initiative Targeting GLP-1 Weight Management Market
Newsfile Corp • STOCK • 09/06/2026, 08:00:00
Lilly's oral GLP-1 Foundayo (orforglipron) delivered superior A1C control and weight loss in three pivotal type 2 diabetes trials
PRNewsWire • STOCK • 08/06/2026, 16:30:00
Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage
CNBC • STOCK • 08/06/2026, 12:30:37
The Wegovy pill is still dominating the GLP-1 pill market
Market Watch • STOCK • 07/06/2026, 21:35:00